• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 2.84% Nasdaq Down 2.94%

    InVivo Therapeutics Holdings Corp. (NVIV)

    -NasdaqGM
    9.12 Down 0.63(6.46%) Sep 1, 4:00PM EDT
    Add to Portfolio
    Prev Close:9.75
    Open:9.51
    Bid:7.60 x 2000
    Ask:10.50 x 300
    1y Target Est:25.00
    Beta:2.20695
    Earnings Date:Nov 3 - Nov 9 (Est.)
    Day's Range:9.01 - 9.51
    52wk Range:1.88 - 19.68
    Volume:206,193
    Avg Vol (3m):459,058
    Market Cap:246.28M
    P/E (ttm):N/A
    EPS (ttm):-1.43
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for NVIV

    Comparison

    Symbol% ChgMkt Cap
    NVIVDown 6.46%246.28M
    ACORDown 0.63%1.36B
    STEMUp 12.20%49.92M
    ALSE 0.00%398.26K

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.63
    Quarterly EPS Est (Sep-15) :-0.19
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Invivo Therapeutics Holdings Corp., a research and clinical-stage biomaterials and biotechnology company, focuses on developing and commercializing technologies for the treatment of spinal cord injury (SCI). View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback